Literature DB >> 4026190

Albumin analysis in serum of haemodialysis patients: discrepancies between bromocresol purple, bromocresol green and electroimmunoassay.

F E Wells, G M Addison, R J Postlethwaite.   

Abstract

The analysis of serum albumin by bromocresol purple (BCP), by bromocresol green (BCG), and by electroimmunoassay (EIA) has been compared in a mixed group of 100 hospital patients. Good agreement between the immunochemical and BCP methods, but a positive bias with the BCG method led to routine use of the BCP method. In a group of 19 paediatric patients on chronic haemodialysis the mean BCP-albumin was found to be lower than the true albumin, as determined by EIA, whereas the positive bias using the BCG method remained. The difference between BCP-albumin and EIA-albumin in the haemodialysis group varied from 0 to -13 g/L (mean -7.1 g/L) but was effectively constant for most patients over a 3-month period. Possible mechanisms and necessary further investigations are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026190     DOI: 10.1177/000456328502200314

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  5 in total

1.  The Roche Immunoturbidimetric Albumin Method on Cobas c 501 Gives Higher Values Than the Abbott and Roche BCP Methods When Analyzing Patient Plasma Samples.

Authors:  Johanna Helmersson-Karlqvist; Mats Flodin; Aleksandra Mandic Havelka; Xiao Yan Xu; Anders Larsson
Journal:  J Clin Lab Anal       Date:  2016-05-12       Impact factor: 2.352

2.  Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted ischemia-modified albumin levels?

Authors:  Aysel Kiyici; Idris Mehmetoğlu; Hatice Karaoğlan; Hüseyin Atalay; Yalçin Solak; Süleyman Türk
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Analysis of time to event outcomes in randomized controlled trials by generalized additive models.

Authors:  Christos Argyropoulos; Mark L Unruh
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

4.  Serum albumin and risks of hospitalization and death: Findings from the Atherosclerosis Risk in Communities study.

Authors:  Colleen M Shannon; Shoshana H Ballew; Natalie Daya; Linda Zhou; Alex R Chang; Yingying Sang; Josef Coresh; Elizabeth Selvin; Morgan E Grams
Journal:  J Am Geriatr Soc       Date:  2021-07-23       Impact factor: 7.538

Review 5.  A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications.

Authors:  Anna L Goldman; Shalender Bhasin; Frederick C W Wu; Meenakshi Krishna; Alvin M Matsumoto; Ravi Jasuja
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 25.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.